Top Markets
#1 MowCat MowCat +49.46%
#2 aPriori aPriori +24.90%
#3 Velvet Velvet +24.78%
#4 Bitway Bitway +24.55%
#5 OVERTAKE OVERTAKE +18.87%
#6 Fake World Assets Fake World Assets +17.70%
#7 Verus Coin Verus Coin +15.91%
#8 Derive Derive +14.97%
#9 Palladium Network Palladium Network +13.55%
#10 Merlin's Seal BTC Merlin's Seal BTC +13.40%
Coin of the day
MowCat MowCat
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Integrated BioPharma, Inc. Integrated BioPharma, Inc.

Integrated BioPharma, Inc.

INBP
Classement en actions #34627
Integrated BioPharma, Inc., together with its subsidiaries, engages in the... Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment provides warehousing and fulfilment services; and distributes raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
Prix de l'action
$0.16795
Dernière synchronisation: 2026-08-14
Capitalisation boursière
$5.22M
Changement (1 jour)
4.97%
Changement (1 an)
-37.80%
Pays
US
Échange Integrated BioPharma, Inc. (INBP)

Catégorie

Healthcare
Revenus pour Integrated BioPharma, Inc. (INBP)
Revenus en Aug 2026 TTM : 0
Selon les derniers rapports financiers de Integrated BioPharma, Inc., le chiffre d'affaires actuel de l'entreprise (TTM) est de 0. En 2026, l'entreprise a réalisé un chiffre d'affaires de 0 égal à le chiffre d'affaires de l'année 2026, qui était de 0. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Integrated BioPharma, Inc. de 2026 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
Pas assez de données pour les dates fournies.
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US